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PURPOSE. Mutations in CACNA2D4 exon 25 cause photoreceptor dysfunction in humans
(c.2406CA mutation) and mice (c.2451insC mutation). We investigated the feasibility of an
exon-skipping therapeutic approach by evaluating the splicing patterns and functional role of
targeted exons.
METHODS. Splicing of the targeted a2d4 (CACNA2D4) exons in presence and absence of the
mutation was assessed by RT-PCR in vivo on mouse retinae and in vitro in HEK293T cells
using splicing-reporter minigenes. Whole-cell patch-clamp recordings were performed to
evaluate the impact of different Cacna2d4 variants on the biophysical properties of Cav1.4 L-
type calcium channels (CACNA1F).
RESULTS. Splicing analysis revealed the presence of a previously unknown splicing isoform of
a2d4 in the retina that truncates the gene open reading frame (ORF) in a similar way as the
c.2451insC mutation. This isoform originates from alternative splicing of exon 25 (E25) with a
new exon (E25b). Moreover, the c.2451insC mutation has an effect on splicing and increases
the proportion of transcripts including E25b. Our electrophysiological analyses showed that
only full-length a2d4 was able to increase Cav1.4/b3-mediated currents while all other a2d4
variants did not mediate such effect.
CONCLUSIONS. The designed exon-skipping strategy is not applicable because the resulting
skipped a2d4 are nonfunctional. a2d4 E25b splicing variant is normally present in mouse
retina and mimics the effect of c.2451insC mutation. Since this variant does not promote
significant Cav1.4-mediated calcium current, it could possibly mediate a different function,
unrelated to modulation of calcium channel properties at the photoreceptor terminals.
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Exon-skipping therapeutic approaches offer a unique oppor-tunity for intervention in patients affected by retinal
dystrophies, as different types of mutations can be potentially
treated in a patient-specific way.1 Among the potential
applications, it is possible to use different antisense molecular
tools to induce intronization of selected exons. This effect can
be achieved by masking cis-acting elements on the pre-mRNA
important for an exon to be recognized as such by the splicing
machinery.2 This strategy can be beneficial where the targeted
exons are carrying nonsense mutations or insertions/deletions
leading to frameshift. However, the precise splicing pattern of
the mutated target exon(s) and the functionality of the skipped
protein need to be carefully evaluated. This approach has been
successfully applied to Duchenne muscular dystrophy (DMD).
Dystrophin function, impaired in DMD by different types of
mutations affecting the reading frame of the gene, can in fact be
restored by skipping of different exons. This results in a shorter
version of the protein, lacking the portion encoded by the
skipped exons but maintaining the reading frame after the
deletion.3 We selected the CACNA2D4 gene as a potential
therapeutic target in the retina: This gene encodes for a2d4, a
member of a2d accessory subunits of high voltage activated
(HVA) calcium channels.4 High voltage activated calcium
channels are multiprotein complexes composed of an a1
subunit, which constitutes the channel pore, and different
accessory subunits (a2d, b, and in some cases c). a2d subunits
are known to regulate HVA calcium channels mainly by
increasing channel presence on the cell membrane, and by
modulating channel gating properties.5 They are translated as a
single protein but then cleaved into a2 and d peptides, which
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are subsequently joined together by a disulphide bond. The a2
peptide is extracellular, while the d mediates membrane
anchoring.6 In the retina, a2d4 is the main accessory subunit7–9
where it is suggested to form a complex with Cav1.4 a1 and b2
subunits,10 since mutations in all these genes are linked to
retinal dystrophies.7,9,11,12 So far, two mutations in Cacna2d4
exon 25 have been reported to cause cone and cone-rod
dystrophies in a human family and in a spontaneous mouse
model.7,8 Both mutations are expected to result in a truncated
protein, likely to be nonfunctional due to the loss of the d
peptide and other functional domains downstream of the
mutation (Fig. 1A). Since the skipping of the sole mutation-
carrying exon 25 in a2d4 would result in frameshift, skipping of
exons 23 to 26 (a2d4 DE23-26) or of exons 23 to 25 (a2d4 DE23-
25) is needed to restore the reading frame downstream of the
skipped exons. We hypothesized that this strategy would result
FIGURE 1. Scheme of Cacna2d4 transcript and computational analysis of exon 25 splicing. (A) Schematic representation of Cacna2d4 transcript
(not in scale). The various exons are numbered. Positions of the von Willebrand factor A (VWF-A) domain43,44 and of the two Cache45 domains of
the protein are shown. The murine c.2451insC mutation site and the resulting nonsense codon are indicated by black arrowheads. (B) IGV
visualization of the RNA-seq eye sample GSM737548 aligned to Cacna2d4 genomic sequence. Position of E25b has been included. Junctions
represent reads spanning over two exons: Alternative splicing of E25 and E25b can be observed. (C) SpliceAid prediction of E25 exonic splicing
enhancers (ESE, positive scores) and silencers (ESS, negative scores). Predictions present only on the mutant E25 are boxed. The mutation mainly
creates ESSs with high scores. The location of the insertion on E25 is underlined in black.
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in a rescued protein missing the skipped exons, but retaining
the d peptide and other structural elements. Moreover, the
targeted exons do not contain any known domain important
for a2d function. The presence of a mouse model7 and the
ability to test the functionality of the skipped protein by
electrophysiology offer a clear advantage in assessing the
feasibility of this exon-skipping approach. We thus generated
constructs lacking these exons and tested their functionality by
electrophysiology in cells in which the whole channel
complex had been reconstituted.
METHODS
Computational Analysis of Cacna2d4 E25 Splicing
Mouse eye RNA-sequencing samples were downloaded from
the Gene Expression Omnibus13 (dataset ID GSE38359: sample
IDs GSM945628, GSM945631, and GSM945634; dataset ID
GSE29752: samples GSM737548 and GSM737550). Reads were
trimmed at the 30 end by removing nucleotides having Q score
< 30 with Trimmomatic,14 and then mapped to the mouse
genome (mm10 assembly) with TopHat2.15 The resulting
alignment and the observed exon–exon junctions were
eventually visualized with Integrative Genomics Viewer
(IGV).16
The genomic sequence of Cacna2d4 between E22 and E27
was analyzed using NNSPLICE 0.9,17 and scores for the
different splice sites were reported.
Cacna2d4 and CACNA2D4 E25 sequences were analyzed
using SpliceAid18 in presence and absence of the c.2451insC
mutation, obtaining predictions of differentially binding
splicing regulatory elements.
Animals
Cacna2d4 mutant and wild-type (WT) mice with C57BL/10
background7 (2 months old) were used for retinal tissue
extraction. C57BL/6 mice (3–5 months old) were used for
analysis of Cacna2d4 DE16 expression in the central nervous
system (CNS). Experiments were approved by the Italian
Ministry of Health and conducted in conformity with the
European Community Directive 2010/63/EU and the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research.
Cloning
Cacna2d4 DE16 clone (GenBank: BC141091.1; IMAGE ID
9055703) was ordered from Source Bioscience (Nottingham,
UK), amplified by PCR using primers For 5 0-GACTGC
TAGCCACTTGCATGC and Rev 50-CTTGTCGACGTCAGATGG
GAT, and cloned into pIRES2-EGFP (Clontech, Mountain View,
CA, USA) using NheI and SalI restriction sites. Exon 16 was
subsequently amplified from murine genomic DNA using
primers For 5 0-AGCTGGCACCCCGATATAAGCTTGGGGTG
CATGGC and Rev 5 0-AGCTTCTTGCCTTCTCTGTA
CAAAGGTCGGAGGTCAG. The resulting PCR fragment was
used as megaprimer19 for site-directed mutagenesis (Quick-
change II site-directed mutagenesis kit; Agilent, Santa Clara, CA,
USA) and added to Cacna2d4 DE16 to generate Cacna2d4 full-
length (a2d4). The c.2451insC mutation on E25 was introduced
by site-directed mutagenesis of Cacna2d4 using primers For 50-
GAGCAGCCCCCCCGGCAGCTTTGTCTTC and Rev 50-GAAGA
CAAAGCTGCCGGGGGGGCTGCTC. The obtained construct
was named a2d4 MUT. E25b was amplified from mouse retina
cDNA using primers For 50-AGAGTCAGAGCCTGGCGTGG and
Rev 50-CTGCTGCAATGGCCGTCTTCC. The PCR product was
extracted from gel to avoid E25-containing transcript and
purified. The product was then used as megaprimer for site-
directed mutagenesis to obtain E25b inclusion in place of E25
(a2d4 E25b). The a2d4 full-length construct has been subse-
quently utilized as template for the generation of a2d4 DE23-25.
For this intent, a PCR using primers For 50-atagcccaggcaagccagt
and Rev 50-actccaggtctggatccac was performed, followed by
ligation of the PCR product. The a2d4 DE23-26 cDNA construct
was obtained from overlapping PCR on Cacna2d4 template. For
this purpose two different primer pairs were used to originate
the two overlapping fragments: For 50-CTACGTGACTGCTAGC
CACTTGCATGCCCAGGA and Rev 5 0-ATCTGGATGCCCACA
GACTCCAGGTCTGGATCC for first reaction; For 50-GATCCA
GACCTGGAGTCTGTGGGCATCCAGATG and Rev 5 0-CTAC
GACTCTTGGATCCGTCAGATGGGATGGAGTC for the second
reaction. The two generated fragments were then purified and
used together with the primer pair For 50-GACTGCTAGC
CACTTGCATGC and Rev 50-CTTGTCGACGTCAGATGGGAT in
a different PCR reaction to generate a2d4 DE23-26. The
Cacna2d4 minigene construct was assembled from four
fragments amplified from mouse genomic DNA and digested
with specific restriction enzymes. For a detailed list of utilized
primers and restriction enzymes see Supplementary Table S1.
The resulting digested and purified fragments were ligated
together with a pCDNA3-Luc2 vector digested with HindIII and
XhoI. The introduction of c.2451insC mutation into the
minigene was performed by site-directed mutagenesis using
the same primer pair utilized for a2d4 MUT.
TheCACNA2D4human clone (GenBank: EU832243.1; IMAGE
ID: 100067272) was ordered from Source Bioscience, amplified
by PCR using primers For 5 0- gaaccgtcagatccgctagcGTA
CAAAAAAGCAGGCTCCACCATG and Rev 50- gggcccgcggtaccgtc
gactACCGCAGGAGTTGGGGCA, and cloned by Gibson assembly
(New England Biotech, Ipswich, MA, USA) into a pIRES2-EGFP
(Clontech) digested with NheI and SalI restriction enzymes. The
generated construct was used as positive control in Western
blots. All obtained clones were checked by sequencing.
RNA Extraction and cDNA Synthesis
Each tissue was dissected from three adult mice and pooled.
Total RNA was extracted using Trizol Reagent (Life Technolo-
gies, Carlsbad, CA, USA), treated with DNase (Roche, Basel,
Switzerland), and purified using NucleoSpin RNA columns
(Macherey-Nagel, Du¨ren, Germany). Complementary DNA
synthesis was performed using random excimers (SuperScript
VILO cDNA Synthesis Kit; Life Technologies). RNA extraction
of transfected HEK293T cells was performed 2 days after
transfection as described above.
Cell Culture and Transfection Conditions
Cells used for electrophysiological recordings were tsA-201,
also called HEK293T.20,21 These are HEK293 cells that
constitutively express the SV40 large T antigen to achieve
higher level of expression from transfected plasmids. We kept,
however, the distinct nomenclature used by the laboratories of
origin since in electrophysiological studies tsA-201 is still the
prevalent name adopted. HEK293T cells were maintained in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented
with 10% FBS, 2 mM glutamine and 100 U/lL Pen/Strep and
grown at 378C, 10% CO2. For transfection with minigenes,
Lipofectamine 2000 (Life Technologies) was used. For electro-
physiological recordings, tsA-201 cells were split into 6-cm
dishes 1 day before transfections. Transfection was performed
using Turbofect transfection reagent (Thermo Scientific,
Waltham, MA, USA) with 0.5 lg Cav1.4 a1,22 0.5 lg b3,23 and
0.5 lg different a2d constructs in pIRES2-EGFP-expressing
vectors and 1 lg pUC. The a2d1 sequence utilized was
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described previously.24 For a2d124 transfections, 0.05 lg of a
Green fluorescent protein (GFP)-expressing plasmid was
cotransfected. One day after transfection, cells were seeded
at low confluence on 3-cm dishes coated with poly-D-lysine
and stored overnight at 308C, 5% CO2. Recordings were
performed the following day. In experiments in which different
a2d constructs were present in the same transfection, the
following amounts were used: 0.5 lg Cav1.4 a1,22 0.5 lg b3,23
0.5 lg each different a2d subunit, and 0.5 lg pUC.
RT-PCR and Densitometric Analysis
The PCR protocol consisted of denaturation (948C; 1 minute),
35 amplification cycles (948C, 30 seconds; 588C, 30 seconds;
728C, 1 minute), and final extension (728C, 7 minutes); primers
are reported in Supplementary Table S2. Densitometric analysis
was conducted using Imagelab 2.0 software (Bio-Rad, Hercules,
CA, USA). Band intensities, corrected for background, were
normalized to the corresponding glyceraldehyde 3-phosphate
dehydrogenase (Gapdh) values.
RT-Quantitative PCR
Reverse transcription–quantitative (q)PCR was performed in a
C1000 thermal cycler with a CFX384 real-time detection
system (Bio-Rad), using the KAPA SYBR FAST master mix (Kapa
Biosystems, Cape Town, South Africa). Gapdh was used as a
reference gene for normalization, using the DCt method.
Primers are reported in Supplementary Table S2. Data were
analyzed using the CFX Manager 2.1 software (Bio-Rad). For
direct comparison of E25 and E25b transcript levels, amplifi-
cation efficiency and y-intercept with the two primer pairs
were compared using serial dilutions of plasmid containing
E25 or E25b. Equivalence of the obtained slopes and y-
intercept was assessed with extra sum-of-square F test. Data are
shown as 2^(-DCt(E25))/2^(-DCt (E25b)).
Protein Extraction and Western Blot
The tsA-201 cells transfected with all the constructs used for
electrophysiological analyses as described above were de-
tached from 6-cm dishes using PBS, centrifuged briefly to
remove PBS, and lysed with 100 lL lysis buffer (50 mM Tris-HCl
pH 8, 150 mM NaCl, Tergytol-type NP-40 (NP-40) 1%, Na-
deoxycholate 0.25%, 1 mM EDTA, 2 mM Phenylmethanesul-
fonyl fluoride (PMSF), 2 mM sodium orthovanadate, 0.1 M
protease inhibitors cocktail [Sigma-Aldrich Corp., St. Louis,
MO, USA]). Protein concentration was assessed using Pierce
BCA protein assay kit (Thermo Scientific). One hundred
micrograms proteins (50 lg in the case of transfections with
human a2d4) was run on a precast 3% to 8% Tris-Acetate gel
(Life Technologies). Proteins were transferred to a Hybond ECL
nitrocellulose membrane (Sigma-Aldrich Corp.) using a transfer
buffer (25 mM Tris-HCl, 192 mM glycine, 20% methanol, 0.1%
SDS). The membrane was blocked for 1 hour at room
temperature by exposure to 5% nonfat dry milk in 20 mM
Tris-HCl pH 8, 0.5 M NaCl, 0.1% Tween-20 (Sigma-Aldrich
Corp.). The membrane was then incubated overnight at 48C
with rabbit polyclonal anti-human CACNA2D4 antibody, 1:400
(Sigma-Aldrich Corp.) or for 1 hour at room temperature with
mouse monoclonal anti-rat b-tubulin antibody, 1:10,000 (Santa
Cruz, Dallas, TX, USA). As secondary antibody, a goat anti-
rabbit horseradish peroxidase (HRP) conjugated IgG-HRP or a
goat anti-mouse IgG-HRP, 1:10000 (Santa Cruz) was used for 1
hour at room temperature. A chemiluminescence-based kit
(Amersham ECL Select Western Blotting Detection Reagent; GE
Healthcare, Little Chalfont, UK) was used for detection.
Electrophysiological Recordings
Whole-cell patch-clamp experiments were performed using an
Axopatch 700B amplifier (Molecular Devices, Sunnyvale, CA,
USA). Borosilicate glass pipettes (external diameter 1.5 mm,
wall thickness 0.32 mm; Science Products, Frankfurt/Main,
Germany) were pulled using a micropipette puller (P97; Sutter
Instruments, Novato, CA, USA) to obtain electrodes with a
resistance of 1.5 to 3 MX. pClamp10.2 (Molecular Devices) and
Prism 5 (GraphPad, La Jolla, CA, USA) software was used for
data analysis. Recordings were executed at pH 7.4 (with
CsOH). The internal solution contained (in mM) 135 CsCl, 10
HEPES, 10 EGTA, 1 MgCl2, and the bath solution 15 CaCl2 or
BaCl2, 10 HEPES, 150 choline-Cl, 1 MgCl2. Recordings were
performed at room temperature (198–228C). All voltages were
corrected for a liquid junction potential of 8mV. In all
protocols used, a holding potential of98mV was applied. To
determine current densities, peak current amplitudes were
normalized to the membrane capacitance. For each analyzed
cell, the maximum observed current density (CDmax) was
reported. Protocols for the voltage dependence of activation
and inactivation, as well as calcium-dependent inactivation,
were used as described by Burtscher and colleagues.11
Statistics
Statistical analysis was performed with Prism 5 (GraphPad) and
significance set at P < 0.05 for all tests. The PCR data are
represented as mean 6 SD and compared using unpaired two-
tailed Student’s t-test. Standard deviation was calculated from
biological replicates. Electrophysiological data are represented
as mean 6 SEM and analyzed by Kruskal-Wallis test followed by
Dunn’s post hoc test for multiple comparisons. Mann-Whitney
U test was used for single comparisons.
RESULTS
Computational Analysis of Cacna2d4 Exon 25
Splicing
We first investigated the feasibility of an exon-skipping
approach for the c.2451insC mutation (previously annotated
as c.2367insC) in exon 25 of Cacna2d47 (registered sequence
NM_001033382.2). We first analyzed the splicing pattern of
this and surrounding exons by an in silico approach using RNA-
seq data from four eyes and one retina of C57BL/6 mice.
Datasets showed that the canonical exon 25 (128 bp) was not
always included in the final transcript. In these cases it was
substituted by a new exon included between exon 24 and 26
(Fig. 1B). This putative exon of 205 bp, named E25b, is located
in intron 25 in close proximity to exon 25. If E25b is included
instead of E25, it terminates the open reading frame (ORF) of
Cacna2d4 in a way similar to the known mutation c.2451insC,
as it carries a stop codon. E25b was present in fewer reads
compared to E25, suggesting that it may be included in a
smaller fraction of Cacna2d4 transcripts. To further corrobo-
rate the existence of this new exon we undertook a
bioinformatics analysis of the 50 and 30 splice sites of E25b
(Table 1) and discovered that the putative E25b showed higher
prediction scores with respect to the canonical E25. In
particular, the 30 splice site of E25 is very weak, while the 30
splice site of E25b is relatively strong. This strengthens the idea
that E25b may be included in place of E25, thereby generating
an alternatively spliced variant of Cacna2d4. Moreover, it
suggests that nucleotide variations in E25 sequence may
significantly affect its inclusion levels in mature transcripts,
favoring E25b-containing transcripts. We hypothesized that the
c.2451insC insertion could have such an effect, and compu-
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tationally tested whether it might increase E25b inclusion
using the SpliceAid web server.18 The output of the
comparisons between WT and mutant E25 revealed how the
insertion in E25 mainly establishes new exonic splicing
silencers (ESS) (Fig. 1C). In fact, the prediction showed seven
new ESS with scores between 4 and 7 in the mutant and
only one new exonic splicing enhancer (ESE) with a score of 4
(Supplementary Table S3), all absent in the WT sequence. We
thus predicted a change in the ratio of E25- and E25b-
containing transcripts between WT and mutant alleles, with
the c.2451insC insertion favoring E25b inclusion. These results
were supported by analyzing the effect of human c.2406CA
mutation in E25, where a predicted ESE is abolished and
substituted with an ESS (Supplementary Fig. S1).
In Vivo and In Vitro Characterization of Exon 25
Splicing
We then verified the above hypothesis by analyzing E25
splicing in retinae of Cacna2d4 WT and mutant mice.7 We
performed an RT-PCR using primers on exon 24 and 26 to
confirm the presence of E25b along with E25 thanks to a clear
difference in size (Fig. 2A). Densitometric analysis of PCR
products revealed that E25b is less abundant than E25 in
mature transcripts found in WT retinae. A significant decrease
in E25-containing transcripts was instead observed in the
mutant retina (Fig. 2B), while E25b levels remained constant.
Reverse transcription–qPCR performed with specific primers
for exon 25 and exon 25b confirmed that E25-containing
transcripts were significantly diminished in mutant mice
compared to WT; E25b-containing mRNAs were also reduced,
although to a much lower extent (Fig. 2C). Quantification of
E25- and E25b-containing transcripts revealed that the ratio
between the two isoforms changed in favor of E25b in mutant
animals (Fig. 2D).
We next assessed the effect of the mutation using a
minigene reporter system, generated by cloning the exons
surrounding E25 (exons 22–27) together with portions of
intronic sequences (introns 22–26) in an expression cassette
(Fig. 2E). Following minigene transfection in HEK293T cells,
proper splicing between the different exons was observed by
RT-PCR using primers on E22 and on the plasmid downstream
of E27 (Fig. 2F). Minigene analysis also showed alternative
splicing between E25 and E25b, as previously described in
vivo. Interestingly, in HEK293T cells the effect of the mutation
was to increase E25b inclusion without affecting E25 levels, as
observed by densitometric analysis of the RT-PCR (Fig. 2G) and
confirmed by RT-qPCR (Fig. 2H) for the two isoforms. The ratio
of E25 over E25b levels revealed that the ratio between the two
isoforms tended to change in favor of E25b in mutant animals
(Fig. 2I).
Analysis of a2d4 DE16 Splicing Isoform Expression
in the CNS and Neuroendocrine System
By database analyses, we found the presence of another
putative splicing isoform of Cacna2d4, obtained from the
sequencing of a whole-brain cDNA library. This isoform is
characterized by the absence of exon 16 (a2d4 DE16; GenBank:
BC141091.1), an exon that encodes for a portion of the first
Cache domain of a2d4, which is conserved in all known a2d
subunits.6 We thus investigated the presence of this isoform in
retina, CNS, and the neuroendocrine system by RT-PCR (Fig.
3A). The DE16 isoform was absent in the retina and in the
pituitary gland, where all Cacna2d4 transcripts contained E16.
Instead, DE16 mRNA was the predominant isoform expressed
in cerebellum, hippocampus, occipital cortex, and somatosen-
sory cortex; both variants were present in hypothalamus.
Densitometric analysis showed that Cacna2d4 is highly
expressed in the retina, while lower levels were detected in
other areas of the CNS (Fig. 3B).
Functional Characterization of Different a2d4
Variants
Since the alteration of the a2d4 ORF due to protein truncation
(for a2d4 MUT and a2d4 E25b) or to partial deletion (for a2d4
DE23–25, a2d4 DE23–26, and a2d4 a2d4 DE16) could potentially
result in protein instability, we confirmed by Western blot the
presence of the different a2d4 variants in tsA-201 cells after
transfection. As shown in Figure 4, a2d4 is present in all
conditions tested (lines 2–7) and absent in tsA-201 (line 1). The
a2d4 MUT and a2d4 E25b show the smallest dimension, since in
both cases the protein is truncated after exon 25. The a2d4
DE16 is instead very close to the WT, as it is missing only exon
16. The two constructs a2d4 DE23 to 25 and a2d4 DE23 to 26
show an intermediate size, since they lack three or four exons
compared to the WT, but retain the portion of the protein
downstream, which is instead not present in a2d4 MUT and
a2d4 E25b.
The a2d accessory subunits have different effects on HVA
calcium channels: They primarily increase calcium influx by
increasing the number of channels on the plasma mem-
brane25–28; in addition, they fasten the inactivation kinetic of
some HVA calcium channels.27,29,30 To identify how a2d4
subunit modulates Cav1.4 L-type calcium currents, we
TABLE 1. Splice-Site Sequences and Scores for Cacna2d4 Exons 22 to 27
Score Sequence 50 > 30
E22 50splice site 0.52 ctggagtgtgagttc
E23 30splice site 0.92 ttcctgtgactttaccctcaggtgacgaggaactggtgcgg
E23 50splice site 0.85 tctctgagtacgtac
E24 30splice site 0.93 tgttgttgctttgcctcgcagagagtcagagcctggcgtgg
E24 50splice site 0.99 ctgacaggtgagccc
E25 30splice site 0.43 acatcaatcctactctcacaggaagttcctgacccctgaag
E25 50splice site 0.92 ggaccaggtaacgga
E25b 30splice site 0.93 cctctctgtgctcttccccagagtggaaaaagggagatgtg
E25b 50splice site 0.99 tcccaaggtgagatc
E26 30splice site 0.98 caataattctcatttttccagatagcccaggcaagccagtg
E26 50splice site 1.00 gcagcaggtaagagc
E27 30splice site 0.98 cctccttcctgtttcctgcagctgtgggcatccagatgcaa
A perfect match with the canonical 30 or 50 splice site sequence is indicated by 1. E25b scores are higher than those of E25, reflecting stronger
splice sites.
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FIGURE 2. Qualitative and quantitative analysis of exon 25 alternative splicing in presence and absence of c.2451insC mutation. (A) Representative
RT-PCR of WT and mutant mouse retinae. Plasmids containing Cacna2d4 sequence with E25 (pE25) or with E25b (pE25b) were used as controls.
Presence of both E25 and E25b can be observed. (B) Densitometric analysis of the RT-PCR on WT and mutant mouse retinae reveals a reduction of
E25-containing plasmid (P < 0.05). (C) Quantification of Cacna2d4 E25, E25b, and 30 UTR using RT-qPCR of WT and mutant mouse retinae (n¼3).
A more pronounced reduction of E25 (P < 0.001)- compared to E25b (P < 0.05)-containing transcripts was observed. (D) Relative abundance of
E25- over E25b-containing transcripts in mouse retinae. The mutation favors E25b presence (P < 0.001). (E) Schematic representation of Cacna2d4
splicing-reporter minigene. The length of the different exons (boxes) and introns (straight lines) is shown. Alternative splicing events leading to
E25b inclusion are reported with dashed lines. The position of primers used in RT-PCR is shown with arrows. (F) Representative RT-PCR of
HEK293T cells transfected with WT (WT MINI) and mutant (MUT MINI) minigenes. The first line shows the occurrence of proper splicing between
all exons included in the minigene. Two bands, close to 850 bp, are distinguishable. The lower is caused by E25 inclusion, the upper by E25b. The
second line confirms the presence of E25b-containing transcripts alongside E25-containing ones. (G) Densitometric analysis of the RT-PCR on WT
and mutant minigenes. The mutation acts on minigene splicing by favoring E25b inclusion. (H) Quantification of the two splicing isoforms (E25/
E25b) in presence or absence of the mutation, by means of RT-qPCR in cells transfected with the minigenes (n¼2). Data confirm that the mutation
causes an increase in the levels of the splicing isoform including E25b (P < 0.01). (I) Relative abundance of E25- over E25b-containing transcripts in
HEK293T cells transfected with minigene splicing reporter systems. The mutation favors E25b presence.
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undertook whole-cell patch-clamp recordings in tsA-201 cells
transfected together with b3 subunits and compared its
biophysical properties with the more frequently investigated
a2d1.11,31 Coexpression of full-length a2d4 resulted in a 3-fold
increase in current density, similarly to a2d1 (Figs. 5A, 5B, 5D).
In addition, a2d4 and a2d1 displayed comparable voltage-
dependent activation and inactivation properties (Fig. 5C;
Table 2). We finally tested the effect of a2d4 on calcium-
dependent inactivation of Cav1.4, and identified no differences
in the inactivation kinetic between Ba2þ- and Ca2þ-driven
currents. The percentage of remaining current during 250-ms
test pulse to 2 and 12 mV (which was the voltage of the
maximum current with Ba2þ and Ca2þ) was 90% for Ba2þ and
91% for Ca2þ, with no significant difference observed (P ¼
0.56). No difference was found over a voltage range from 40
to þ40 mV, as also previously noted with a2d1 using the same
experimental settings.11 Similar results were fairly recently
reported also for human a2d4 subunits.10
Since our primary aim was to test the feasibility of exon
skipping as a potential therapeutic approach for a2d4 mutant
subunits, we assessed the functionality of proteins missing
either three (E23-24-25) or four (E23-24-25-26) exons. Neither
construct increased current densities and both were compa-
rable to our negative control (Cav1.4, b3, and pIRES vector)
(Fig. 5D; Table 2). We also characterized the electrophysiolog-
ical properties of the E25b isoform, which we expected to
mimic the c.2451insC mutant, and the DE16 variant: none of
these variants evoked a change in current density levels (Figs.
5A, 5B, 5D; Table 2), and activation gating properties of Cav1.4
were not altered with any of the variants for which we were
able to obtain an activation curve (Fig. 5C; Table 2). We finally
tested whether we could exert a possible dominant negative
effect of the different splicing isoforms or the mutant by
expressing them together with full-length a2d4 in a 1:1 ratio.
We ruled out a possible dominant negative effect of the
different splicing isoforms as no changes in current densities
were appreciated if compared to a2d4 alone (Fig. 6).
DISCUSSION
We discovered that the previously described c.2451insC
mutation,7 causing retinopathy in mice, apart from truncating
the ORF of the gene after the first Cache domain, also affects
splicing. The mutation favors inclusion of a newly identified
alternatively spliced exon, E25b, which also terminates the
ORF. The mutation created new ESSs on E25 and promoted
E25b inclusion in place of E25. In vivo, the mutation mainly
affected E25, impairing its incorporation in mature mRNA.
With use of a minigene reporter system in HEK293T cells, its
effect is instead to favor E25b inclusion, without significantly
affecting E25 levels. The observed difference of action could be
due to the presence of different trans-acting splicing factors in
the two analyzed systems: HEK293T cell line and mouse
retinae. Differences in the impact of nonsense-mediated decay
on the overall levels of transcripts32 might also be involved,
FIGURE 3. Analysis of a2d4 DE16 splicing isoform presence in the CNS
and neuroendocrine system. (A) RT-PCR with primers flanking E16 on
mouse hippocampus (HC), pituitary gland (PG), hypothalamus (HPT),
occipital cortex (OC), somatosensory cortex (SSC), cerebellum (CB),
and WT (RET WT) and mutant (RET MUT) retina. (B) Densitometric
analysis of RT-PCR results from the displayed image.
FIGURE 4. Expression of the different a2d4 variants in tsA-201 cells after transfection. A specific band for a2d4 is visible following tsA-201
transfection with Cav1.4 a1, b3, and constructs encoding all the different a2d4 variants utilized (lanes 2–7). The a2d4 band changes in size
accordingly to the relative length of the expressed variant. In the negative control (lane 1), a2d4 is not detectable, proving the absence of
endogenous a2d4 in tsA-201 cells. A condition in which human a2d4 was transfected (a2d4 human) has been added as an additional positive control
(lane 8).
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FIGURE 5. Effect of different a2d4 variants on Cav1.4-mediated current density. (A) Scheme of the recording protocol and representative sample
traces for some of the different tested conditions. (B) Representation of the changes in current density at the different voltages tested for a2d1, a2d4,
a2d4 E25b, a2d4 MUT (c.2451insC), a2d4 DE16, pIRES (empty vector). Mean values, SEM, and the best fits of the current voltage relation are shown.
The total number of cells considered for each curve is reported in parentheses. (C) Voltage-dependent activation curve of a2d1, a2d4, a2d4 E25b,
a2d4 MUT (c.2451insC), a2d4 DE16, pIRES (empty vector). (D) Maximal current densities of cells measured in the presence of different a2d4 subunits
in comparison to a2d1 and pIRES. For each condition, mean and SEM are shown. Selected pairs of conditions were compared using Kruskal-Wallis
test followed by Dunn’s multiple comparison posttest (***P < 0.001).
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especially in vivo where we see a general reduction of
Cacna2d4 mRNA.
Our findings are also pathophysiologically relevant, since
we confirmed the predicted role of murine a2d4 as an
accessory subunit of Cav1.4 by characterizing its biophysical
properties. This subunit is able to increase current densities by
3-fold in a heterologous expression system, in accordance with
the changes in calcium influx previously described using
human a2d4.4 Moreover, a2d4 has no effect on the activation
properties of Cav1.4 and is comparable to a2d1 when
inactivation is investigated. We therefore suggest that, since
a2d4 is highly expressed in the retina together with Cav1.4,
where both localize to photoreceptor terminals,9,33–35 this is
likely the subunit helping trafficking of Cav1.4 to the plasma
membrane of photoreceptors, as it is able to mediate the same
effect on the channel in a heterologous system.
The a2d4 isoform resulting from E25b inclusion completely
lacks the d peptide, important for membrane anchoring.6,36
Even if a2d subunits lacking the membrane anchor site are still
able to enhance calcium currents, they lose this ability when
the whole d peptide is deleted.36,37 Indeed, a2d4 c.2451insC
and a2d4 E25b did not increase current densities. Therefore,
the role of the a2d4 E25b splicing isoform in the retina remains
elusive, as the protein would be secreted. Elucidation of the
presence of a splicing event in human CACNA2D4 that
resembles the effect of murine E25b incorporation would be
important. Specifically, if an alternatively spliced exon truncat-
ing CACNA2D4 ORF between the two Cache domains exists
also in the human gene, also in this case the c.2406CA
mutation could favor this inclusion.
We show that the region encoded by exons 23 to 26 is of
fundamental importance for the functionality of a2d4. The
removal of this portion indeed impairs the ability of a2d4 to
promote calcium currents mediated by Cav1.4 a1 subunits. The
region encoded by these exons spans between the two Cache
domains and is not part of any known domain of the protein.
Moreover, in an a2d1 paralogue, insertion of an HA tag in the
corresponding region did not affect the protein’s ability to
mediate an increase in currents.36 This region may host
glycosylation sites important for its functionality.37 This
impairs our therapeutic strategy aimed at correcting the
retinopathy caused by c.2451insC mutation, since this strategy
was relying on the therapeutic skipping of exons 23 to 26 or 23
to 25 from transcripts in order to eliminate the frameshift
mutation on E25 and restore the ORF downstream of it.
We described the presence of two newly identified splicing
isoform (Cacna2d4 E25b and Cacna2d4 DE16) that were
unable to influence Cav1.4 currents. In keeping with previous
studies,38 Cacna2d4 DE16 is present at low levels in the
analyzed CNS areas. Moreover, in a recent study, a smaller
(~165kDa instead of ~170kDa) a2d4 was detected by Western
blots in mouse brain, possibly being a2d4 DE16.33 These results
strengthen the current hypothesis39 that a2d subunits may
fulfill, in the retina and CNS, different functions not directly
related to trafficking of calcium channels on the plasma
membrane. The reason for occurrence of two different
frameshift-causing mutations both on E25 in humans and mice
and the presence of a splicing isoform that recapitulates the
effect of the mutation in mice remains elusive. It is likely that
the mutation, by mimicking the effect of E25b inclusion, offers
a specific advantage in heterozygosity (overdominance) in the
eye or in other districts where a2d4 is normally expressed. This
would allow the conservation of different mutations sharing
the same mimicking effect.
The effect that mutations in the coding region of genes have
on splicing is generally underestimated: It is today believed that
more than a quarter of these mutations interfere with proper
splicing.40–42 As we showed in this work, early investigation of
how splicing patterns change in response to a mutation is of
pivotal importance for the implementation of therapies
involving antisense-mediated splicing-correcting approaches.
TABLE 2. Biophysical Parameters of Different a2d Constructs Coexpressed With Cav1.4 a1 and b3
CDmax V0.5, act Kact V0.5, inact Kinact
a2d4 8.28 6 0.90* N ¼ 44 1.64 6 0.55 N ¼ 29 9.87 6 0.30 N ¼ 29 20.24 6 2.29 N ¼ 15 13.00 6 0.97 N ¼ 15
a2d4 E25b 3.74 6 0.52 N ¼ 16 0.98 6 2.61 N ¼ 9 11.37 6 1.13 N ¼ 9 ND ND
a2d4 mut 3.51 6 0.61 N ¼ 26 1.03 6 1.76 N ¼ 17 10.99 6 0.57 N ¼ 17 ND ND
a2d1 13.12 6 1.60* N ¼ 22 1.05 6 0.44 N ¼ 20 9.11 6 0.17 N ¼ 20 17.81 6 2.27 N ¼ 29 14.39 6 1.28 N ¼ 29
pIRES 2.49 6 0.29 N ¼ 30 0.52 6 2.38 N ¼ 18 10.80 6 0.69 N ¼ 18 ND ND
A2d4 DE16 1.59 6 0.19 N ¼ 18 ND ND ND ND
A2d4 DE23-26 1.64 6 0.33 N ¼ 6 ND ND ND ND
A2d4 DE23-25 0.97 6 0.16 N ¼ 7 ND ND ND ND
Experiments were conducted in tsA-201 cells using 15mM Ca2þ as charge carrier. Data are given as mean 6 SEM. For multiple comparisons
(CDmax; V0.5 act; Kact), significance is given in relation to Cav1.4 a1þ b3 þ pIRES. For single comparison (V0.5 inact; Kinact), significance is given in
relation to Cav1.4 a1þb3þa2d1. Data for a2d1 V0.5 inact and Kinact were taken from Burtscher et al.11 CDmax, maximum current density; V0.5, act, half-
maximum activation voltage; Kact, slope parameter of the activation curve; V0.5, inact, half-maximum inactivation voltage; Kinact, slope parameter of
the inactivation curve; N, sample size; ND, not determined.
* P < 0.001, statistically significant differences.
FIGURE 6. Effect of the coexpression of full-length a2d4 with other
a2d4 variants. The full-length a2d4 construct was cotransfected with
equal amounts of other a2d4 variants. No significant differences on
maximal current density were observed in any of the tested conditions
as compared with a2d4 þ a2d4, or with a2d4 þ pIRES. As a result no
dominant negative effect of the different variants on a2d4 activity was
observable in the employed experimental conditions.
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To this end, splicing-reporter minigene assays can constitute a
precious ally in this effort: We described here for the first time
the design and use of a minigene system able to properly recall
all splicing events across 6.5 Kb and six different exons. With
the implementation of more efficient gene synthesis services
this powerful approach could become relatively easy to use.
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